Physician profile
Bruce A Samuels
NPI 1083686372
$597,790.62
in general payments reported to CMS, 2019-2025
36 companies · $79K in 2025
The $79K reported for 2025 was more than what 99% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88K · 2020: $61K · 2021: $75K · 2022: $87K · 2023: $55K · 2024: $153K · 2025: $79K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $144K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $51K · Travel and Lodging: $49K · Food and Beverage: $29K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $9,675 · Education: $3,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $144,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $51,326.46 |
| Travel and Lodging | $49,494.03 |
| Food and Beverage | $29,122.15 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $9,675.00 |
| Education | $3,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $442,833.58 | 2019-2025 | Coroflow, Pressurewire, Optis |
| Philips North America LLC | $102,908.09 | 2019-2025 | (9520) Igt Devices Undivided, Igt Devices Undivided, (Bh4) Igt Devices Undivided |
| Cathworks, INC. | $32,800.71 | 2019-2025 | Ffrangio |
| Medtronic, INC. | $6,450.03 | 2022-2023 | Onyx Frontier |
| Shockwave Medical, INC | $5,510.03 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Genentech, INC. | $3,250.00 | 2019 | |
| Abiomed | $1,106.59 | 2021-2025 | Impella |
| Edwards Lifesciences Corporation | $417.32 | 2022-2025 | Sapien 3 Ultra Resilia |
| Cardiva Medical, INC. | $395.23 | 2020-2025 | Cardiva Vascade 5f Vcs, Optowire |
| Biotronik INC. | $343.06 | 2020-2022 | |
| Amgen INC. | $248.90 | 2019-2025 | Repatha, Repatha |
| Acist Medical Systems, INC. | $220.96 | 2019-2021 | |
| Pfizer INC. | $184.31 | 2022-2025 | |
| Boston Scientific Corporation | $170.32 | 2019-2024 | Watchman Access System, Avvigo Guidance System |
| Siemens Medical Solutions USA, INC. | $126.71 | 2019 |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Samuels listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.